Currently, Revolution Medicines Inc [RVMD] is trading at $80.27, down -0.38%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The RVMD shares have gain 3.49% over the last week, with a monthly amount glided 13.26%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Revolution Medicines Inc [NASDAQ: RVMD] stock has seen the most recent analyst activity on November 18, 2025, when Wolfe Research initiated its Outperform rating and assigned the stock a price target of $75. Previously, RBC Capital Mkts started tracking the stock with Outperform rating on November 03, 2025, and set its price target to $77. On October 21, 2025, Mizuho initiated with a Outperform rating and assigned a price target of $90 on the stock. Truist started tracking with a Buy rating for this stock on September 05, 2025, and assigned it a price target of $99. In a note dated August 19, 2025, Piper Sandler initiated an Overweight rating and provided a target price of $75 on this stock.
This stock has fluctuated between a low of $29.17 and a high of $81.62 over the last 52 weeks. Currently, Wall Street analysts expect the stock to reach $82 within the next 12 months. Revolution Medicines Inc [NASDAQ: RVMD] shares were valued at $80.27 at the most recent close of the market. An investor can expect a potential return of 2.16% based on the average RVMD price forecast.
Analyzing the RVMD fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.43, Equity is -0.49 and Total Capital is -0.52. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.1.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 79.55 points at the first support level, and at 78.83 for the second support level. However, for the 1st resistance point, the stock is sitting at 81.35, and for the 2nd resistance point, it is at 82.43.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Revolution Medicines Inc [NASDAQ:RVMD] is 8.05. Also, the Quick Ratio is 8.05, while the Cash Ratio stands at 0.89.
Transactions by insiders
Recent insider trading involved Cislini Jeff, General Counsel, that happened on Dec 16 ’25 when 2688.0 shares were sold. See Remarks, GOLDSMITH MARK A completed a deal on Dec 16 ’25 to sell 15394.0 shares. Meanwhile, See Remarks Kelsey Stephen Michael sold 5447.0 shares on Dec 16 ’25.
